Comerica Bank Sells 561,383 Shares of Option Care Health, Inc. $OPCH

Key Points

• Comerica Bank reduced its ownership in Option Care Health, Inc. by 41.4%, now holding approximately $27.83 million worth of shares.
• Institutional investors and hedge funds own a significant 98.05% of Option Care Health's stock, indicating strong institutional interest in the company.
• Option Care Health reported a 15.4% increase in quarterly revenue year-over-year, contributing to a net margin of 3.93% and a return on equity of 17.53%.

Comerica Bank cut its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 41.4% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 796,245 shares of the company's stock after selling 561,383 shares during the quarter. Comerica Bank owned about 0.49% of Option Care Health worth $27,829,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in the business. Fuller & Thaler Asset Management Inc. grew its holdings in Option Care Health by 30.8% in the 1st quarter. Fuller & Thaler Asset Management Inc. now owns 4,204,481 shares of the company's stock valued at $146,947,000 after buying an additional 989,048 shares in the last quarter. Dimensional Fund Advisors LP lifted its position in shares of Option Care Health by 17.4% during the 4th quarter. Dimensional Fund Advisors LP now owns 3,988,051 shares of the company's stock valued at $92,518,000 after acquiring an additional 591,042 shares during the period. Northern Trust Corp lifted its position in shares of Option Care Health by 11.8% during the 4th quarter. Northern Trust Corp now owns 2,626,478 shares of the company's stock valued at $60,934,000 after acquiring an additional 278,158 shares during the period. Charles Schwab Investment Management Inc. lifted its position in shares of Option Care Health by 4.0% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 2,609,705 shares of the company's stock valued at $91,209,000 after acquiring an additional 99,574 shares during the period. Finally, Nuveen LLC bought a new stake in shares of Option Care Health during the 1st quarter valued at $70,965,000. 98.05% of the stock is owned by institutional investors and hedge funds.

Option Care Health Trading Down 0.2%

Shares of OPCH traded down $0.07 during mid-day trading on Friday, reaching $28.68. 1,554,512 shares of the company were exchanged, compared to its average volume of 1,808,057. Option Care Health, Inc. has a 52 week low of $21.39 and a 52 week high of $35.53. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.00 and a current ratio of 1.52. The stock has a market capitalization of $4.65 billion, a PE ratio of 22.94, a PEG ratio of 1.75 and a beta of 0.79. The business has a 50 day simple moving average of $29.60 and a two-hundred day simple moving average of $31.65.

Option Care Health (NASDAQ:OPCH - Get Free Report) last issued its quarterly earnings data on Wednesday, July 30th. The company reported $0.41 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.40 by $0.01. Option Care Health had a return on equity of 17.53% and a net margin of 3.93%.The company had revenue of $1.42 billion during the quarter, compared to the consensus estimate of $1.35 billion. During the same period last year, the company earned $0.30 earnings per share. The firm's revenue was up 15.4% compared to the same quarter last year. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. On average, analysts predict that Option Care Health, Inc. will post 1.22 earnings per share for the current fiscal year.

Insider Activity at Option Care Health

In other news, Director Harry M. Jansen Kraemer, Jr. acquired 36,000 shares of Option Care Health stock in a transaction on Wednesday, August 20th. The stock was purchased at an average price of $27.15 per share, with a total value of $977,400.00. Following the completion of the purchase, the director owned 375,390 shares of the company's stock, valued at approximately $10,191,838.50. The trade was a 10.61% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Timothy P. Sullivan acquired 20,000 shares of Option Care Health stock in a transaction on Thursday, August 21st. The stock was purchased at an average cost of $27.51 per share, with a total value of $550,200.00. Following the purchase, the director directly owned 49,229 shares of the company's stock, valued at approximately $1,354,289.79. This trade represents a 68.43% increase in their position. The disclosure for this purchase can be found here. Company insiders own 0.64% of the company's stock.

Analyst Ratings Changes

A number of research firms have recently weighed in on OPCH. Citigroup reiterated an "outperform" rating on shares of Option Care Health in a research report on Thursday, July 31st. Barrington Research reiterated an "outperform" rating and set a $38.00 target price on shares of Option Care Health in a research report on Thursday, July 10th. Finally, JMP Securities upped their target price on Option Care Health from $36.00 to $38.00 and gave the company a "market outperform" rating in a research report on Thursday, July 31st. Eight research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat.com, Option Care Health currently has an average rating of "Moderate Buy" and a consensus price target of $35.75.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.